TRPV2 and hepatocellular carcinoma: This study demonstrated that ether-lipids accelerate cancer cell mobility through TRPV2 activation and that pathological PPARα downregulation compromised ether-lipid clearance in HCC, posing significant challenges to cancer prognosis.